ENTRY       D12347                      Drug
NAME        Volrustomig (USAN)
FORMULA     C6528H10050N1736O2026S47
EXACT_MASS  146682.3624
MOL_WEIGHT  146773.1172
SEQUENCE    (A chain)
            QVQLVESGGG VVQPGRSLRL SCAASGFTFS SYGMHWVRQA PGKGLEWVAV IWYDGSNKYY
            ADSVKGRFTI SRDNSKNTLY LQMNSLRAED TAVYYCARDP RGATLYYYYY GMDVWGQGTT
            VTVSSASTKG PSVCPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA
            VLQSSGLYSL SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KRVEPKSVDK THTCPPCPAP
            EFEGGPSVFL FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR
            EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK VSNKALPASI EKTISKAKGQ PREPQVYTLP
            PCREEMTKNQ VSLWCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV
            DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS LSPGK
            (B chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS DYGMHWVRQA PGKGLEWVAY ISSGSYTIYS
            ADSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCARRA PNSFYEYYFD YWGQGTTVTV
            SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
            SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKRV EPKSCDKTHT CPPCPAPEFE
            GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
            YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPASIEKT ISKAKGQPRE PQVCTLPPSR
            EEMTKNQVSL SCAVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LVSKLTVDKS
            RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
            (C chain)
            QIVLTQSPAT LSLSPGERAT LSCSASSKHT NLYWSRHMYW YQQKPGQAPR LLIYLTSNRA
            TGIPARFSGS GSGTDFTLTI SSLEPEDFAV YYCQQWSSNP FTFGQGTKLE IKRTVAAPSV
            FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
            SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
            (D chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQSIN SYLDWYQQKP GKAPKLLIYA ASSLQSGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YYSTPFTFGP GTKVEIKGQP KAAPSVTLFP
            PCSEELQANK ATLVCLISDF YPGAVTVAWK ADSSPVKAGV ETTTPSKQSN NKYAASSYLS
            LTPEQWKSHR SYSCQVTHEG STVEKTVAPT EVS
            (Disulfide bridge: A22-A96, A134-D122, A152-A208, A234-B231, A237-B234, A269-A329, A362-A354, A375-A433, B22-B96, B149-B205, B225-C219, B266-B326, B372-B430, C23-C93, C139-C199, D23-D88 D135-D194)
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Immune checkpoint inhibitor
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      CTLA4 (CD152) [HSA:1493] [KO:K06538]
            PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
  PATHWAY   hsa04514(1493+5133)  Cell adhesion molecules
            hsa04660(1493+5133)  T cell receptor signaling pathway
            hsa05235(5133)  PD-L1 expression and PD-1 checkpoint pathway in cancer
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D12347  Volrustomig
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                CTLA4 (CD152)
                 D12347  Volrustomig (USAN)
                PDCD1 (PD1, CD279)
                 D12347  Volrustomig (USAN)
DBLINKS     CAS: 2407760-40-9
///
